The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Pharmacologic Treatment of the Irritable Bowel Syndrome: A Systematic Review of Randomized, Controlled Trials
Abstract
PURPOSE: To evaluate the efficacy of pharmacologic agents for the irritable bowel syndrome. DATA SOURCES: Electronic literature search of MEDLINE (1966 to 1999), EMBASE (1980 to 1999), PsycINFO (1967 to 1999), and the Cochrane controlled trials registry and a manual search of references from bibliographies of identified articles. STUDY SELECTION: Randomized, double-blind, placebo-controlled, parallel, or crossover trials of a pharmacologic intervention for adult patients that reported outcomes of improvement in global or irritable bowel-specific symptoms. DATA EXTRACTION: Qualitative and quantitative data reported on study groups, interventions, treatment outcomes, and trial methodologic characteristics. DATA SYNTHESIS: 70 studies met the inclusion criteria. The most common medication classes were smooth-muscle relaxants (16 trials), bulking agents (13 trials), prokinetic agents (6 trials), psychotropic agents (7 trials), and loperamide (4 trials). The strongest evidence for efficacy was shown for smooth-muscle relaxants in patients with abdominal pain as the predominant symptom. Loperamide seems to reduce diarrhea but does not relieve abdominal pain. Although psychotropic agents were shown to produce global improvement, the evidence is based on a small number of studies of suboptimal quality. Psychotropic drugs, 5-hydroxytryptamine (5-HT)-receptor antagonists, peppermint oil, and Chinese herbal medicine require further study. CONCLUSIONS: Smooth-muscle relaxants are beneficial when abdominal pain is the predominant symptom. In contrast, the efficacy of bulking agents has not been established. Loperamide is effective for diarrhea. Evidence for use of psychotropic agents is inconclusive; more high-quality trials of longer duration are needed. Evidence for the efficacy of 5-HT-receptor antagonists seems favorable, although more studies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
A method for assessing the quality of a randomized control trial
Chalmers, T. C., Smith, H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., & Ambroz, A. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90056-8 · Cited by 1,349
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761
Medical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 1×
“In community-based studies, persons with the irritable bowel syndrome have greater disability, threefold higher absenteeism from work, and twofold higher average health care costs than do healthy controls (7, 8).”
BackgroundThe Irritable Bowel Syndrome: Long-Term Prognosis and the Physician-Patient Interaction
Owens, D. M., Nelson, D. K., & Talley, N. J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-2-199501150-00005 · Cited by 349
Talley, N. J., Zinsmeister, A. R., & Melton, L. J. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117548 · Cited by 327
The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach
Drossman, D. A., & Thompson, W. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-1009 · Cited by 309 · cited 3×
“Antidepressants are purported to be beneficial and often are used in patients with chronic refractory symptoms, who are known to have a higher prevalence of psychiatric disturbances (96).”
BackgroundInfluential
Cited by
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity and management
Kroenke, K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.140 · Cited by 624
Self-citationFord, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
An irritable bowel syndrome-specific symptom questionnaire: development and validation
K., W. I., S., F., J., H. C., H., J. R., F., L. G., A., M. E., A., P. R., K., W. I., & J., N. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310004209 · Cited by 324
Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis
Lackner, J. M., Mesmer, C., Morley, S., Dowzer, C., & Hamilton, S. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.6.1100 · Cited by 295
The placebo effect in irritable bowel syndrome trials: a meta‐analysis1
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., et al. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00650.x · Cited by 285
Irritable bowel syndrome: A clinical review
Soares, R. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12144 · Cited by 266
Efficacy of alosetron in irritable bowel syndrome: a meta‐analysis of randomized controlled trials
Cremonini, F., Delgado‐Aros, S., & Camilleri, M. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00389.x · Cited by 219
Zhao, L., Yang, W., Chen, Y., Huang, F., Lu, L., Lin, C., Huang, T., Ning, Z., Zhai, L., Zhong, L. L. D., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130976 · Cited by 202
Quartero, A. O., Meiniche-Schmidt, V., Muris, J., Rubin, G., & de Wit, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub2 · Cited by 190
Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders
Costedio, M. M., Hyman, N., & Mawe, G. M. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0763-3 · Cited by 170
Comorbidity of irritable bowel syndrome in psychiatric patients: A review
Garakani, A., Win, T., Virk, S., Gupta, S., Kaplan, D., & Masand, P. S. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200301000-00014 · Cited by 149
Hypnotherapy for treatment of irritable bowel syndrome
Webb, A. N., Kukuruzovic, R., Catto-Smith, A. G., & Sawyer, S. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005110.pub2 · Cited by 147
Lindfors, P., Unge, P., Arvidsson, P., Nyhlin, H., Björnsson, E., Abrahamsson, H., & Simrén, M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.340 · Cited by 138
Longstreth, G. F., Hawkey, C. J., Mayer, E. A., Jones, R. H., Naesdal, J., Wilson, I. K., Peacock, R. A., & Wiklund, I. K. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01010.x · Cited by 124
North, C. S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i14.2020 · Cited by 122
Simrén, M., Ringström, G., Björnsson, E. S., & Abrahamsson, H. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000116964.76529.6e · Cited by 111
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
Chey, W. D., Maneerattaporn, M., & Saad, R. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.3.253 · Cited by 89
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome
Corazziari, E., Bytzer, P., Delvaux, M., Holtmann, G., Malagelada, J. R., Morris, J., Muller‐Lissner, S., Spiller, R. C., Tack, J., & Whorwell, P. J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01709.x · Cited by 80
Use of psychopharmacological agents for functional gastrointestinal disorders.
Clouse, R. E., & Lustman, P. J. (2005) · Gut · doi:10.1136/gut.2004.048884 · Cited by 76
Antidepressants for irritable bowel syndrome: Figure 1
Clouse, R. E. (2003) · Gut · doi:10.1136/gut.52.4.598 · Cited by 74
Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs
Oerlemans, S., van Cranenburgh, O., Herremans, P.-J., Spreeuwenberg, P., & van Dulmen, S. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.09.018 · Cited by 67
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome
Lindfors, P., Unge, P., Nyhlin, H., Ljótsson, B., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.658858 · Cited by 60
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain
Williams, R. E., Hartmann, K. E., Sandler, R. S., Miller, W. C., Savitz, L. A., & Steege, J. F. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.10.634 · Cited by 59
Irritable bowel syndrome: a concise review of current treatment concepts
Wall, G. C., Bryant, G. A., Bottenberg, M. M., Maki, E. D., & Miesner, A. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.8796 · Cited by 56
Hutchings, H. A., Wareham, K., Baxter, J. N., Atherton, P., Kingham, J. G. C., Duane, P., Thomas, L., Thomas, M., Ch'ng, C. L., & Williams, J. G. (2011) · ISRN Gastroenterology · doi:10.5402/2011/206103 · Cited by 37
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
The Use of Probiotics in Functional Bowel Disease
Quigley, E. M. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.008 · Cited by 20
Clavé, P. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01808.x · Cited by 12
Metadata
- Authors
- Jailwala, J., Imperiale, T. F., & Kroenke, K.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-07-18
- Volume
- 133
- Issue
- 2
- Pages
- 136-147
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2006750191
- Cited by
- 381
- References
- 12
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
